Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

MitraClip Therapy for Dynamic Mitral Regurgitation With Repetitive Heart Failure Exacerbation.

Masumoto A, Kubo S, Ohya M, Maruo T, Kadota K.

JACC Cardiovasc Interv. 2019 Nov 20. pii: S1936-8798(19)31975-2. doi: 10.1016/j.jcin.2019.09.021. [Epub ahead of print] No abstract available.

PMID:
31786214
2.

Radiofrequency catheter ablation of premature ventricular contractions from near the His-bundle.

Tanaka A, Takemoto M, Masumoto A, Kang H, Mito T, Kumeda H, Aoki R, Kinoshita S, Antoku Y, Matsuo A, Hida S, Okazaki T, Tayama KI, Kosuga KI.

J Arrhythm. 2019 Feb 15;35(2):252-261. doi: 10.1002/joa3.12167. eCollection 2019 Apr.

3.

Changes in prolactin receptor homodimer availability may cause late feathering in chickens.

Okamura A, Masumoto A, Takenouchi A, Kudo T, Aizawa S, Ogoshi M, Takahashi S, Tsudzuki M, Takeuchi S.

Gen Comp Endocrinol. 2019 Feb 1;272:109-116. doi: 10.1016/j.ygcen.2018.12.011. Epub 2018 Dec 27.

PMID:
30594591
4.

Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs.

Watanabe S, Yamaguchi OU, Masumoto AI, Maeno Y, Kawashima Y, Ishimoto O, Sugawara S, Yoshizawa H, Kikuchi T, Nukiwa T, Kobayashi K.

Anticancer Res. 2018 Aug;38(8):4699-4704. doi: 10.21873/anticanres.12776.

PMID:
30061238
5.

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.

Yada M, Miyazaki M, Tanaka K, Masumoto A, Motomura K.

World J Gastroenterol. 2018 Apr 7;24(13):1478-1485. doi: 10.3748/wjg.v24.i13.1478.

6.

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.

Miyazaki M, Yada M, Tanaka K, Senjyu T, Goya T, Motomura K, Kohjima M, Kato M, Masumoto A, Kotoh K.

World J Gastroenterol. 2017 Aug 7;23(29):5379-5385. doi: 10.3748/wjg.v23.i29.5379.

7.

Clinical benefits of deep sedation with a supraglottic airway while monitoring the bispectral index during catheter ablation of atrial fibrillation.

Hida S, Takemoto M, Masumoto A, Mito T, Nagaoka K, Kumeda H, Kawano Y, Aoki R, Kang H, Tanaka A, Matsuo A, Hironaga K, Okazaki T, Yoshitake K, Tayama KI, Kosuga KI.

J Arrhythm. 2017 Aug;33(4):283-288. doi: 10.1016/j.joa.2017.04.001. Epub 2017 May 8.

8.

Inappropriate Sinus Tachycardia Diagnosed and Treated as Depression Successfully Treated by Radiofrequency Catheter Ablation.

Masumoto A, Takemoto M, Mito T, Tanaka A, Kawano Y, Kumeda H, Kang H, Matsuo A, Hida S, Okazaki T, Tayama KI, Yoshitake K, Kosuga K.

Intern Med. 2017;56(5):523-526. doi: 10.2169/internalmedicine.56.7579. Epub 2017 Mar 1.

9.

Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding.

Komori K, Kubokawa M, Ihara E, Akahoshi K, Nakamura K, Motomura K, Masumoto A.

World J Gastroenterol. 2017 Jan 21;23(3):496-504. doi: 10.3748/wjg.v23.i3.496.

10.

Magnesium prevents phosphate-induced vascular calcification via TRPM7 and Pit-1 in an aortic tissue culture model.

Sonou T, Ohya M, Yashiro M, Masumoto A, Nakashima Y, Ito T, Mima T, Negi S, Kimura-Suda H, Shigematsu T.

Hypertens Res. 2017 Jun;40(6):562-567. doi: 10.1038/hr.2016.188. Epub 2017 Jan 26.

PMID:
28123180
11.

Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications.

Nakashima Y, Mima T, Yashiro M, Sonou T, Ohya M, Masumoto A, Yamanaka S, Koreeda D, Tatsuta K, Hanba Y, Moribata M, Negi S, Shigematsu T.

Growth Factors. 2016 Dec;34(5-6):196-202. doi: 10.1080/08977194.2016.1273222. Epub 2017 Jan 18.

PMID:
28095739
12.

Acute heart failure caused by mechanical valve leaflet dislodgment at the mitral position.

Nakamura T, Masumoto A, Tahara N, Kuroda Y, Fukumoto Y.

Eur Heart J. 2017 Mar 7;38(10):761. doi: 10.1093/eurheartj/ehw521. No abstract available.

PMID:
28025190
13.

Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.

Shigematsu T, Sonou T, Ohya M, Yokoyama K, Yoshida H, Yokoo T, Okuda K, Masumoto AR, Iwashita Y, Iseki K, Kunimoto S, Yamano Y.

Contrib Nephrol. 2017;189:169-177. Epub 2016 Dec 12. Review.

PMID:
27951564
14.

Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor.

Masumoto A, Sonou T, Ohya M, Yashiro M, Nakashima Y, Okuda K, Iwashita Y, Mima T, Negi S, Shigematsu T.

J Atheroscler Thromb. 2017 Jul 1;24(7):716-724. doi: 10.5551/jat.36574. Epub 2016 Nov 11.

15.

Cell-free analysis of polyQ-dependent protein aggregation and its inhibition by chaperone proteins.

Machida K, Shigeta T, Kobayashi A, Masumoto A, Hidaka Y, Imataka H.

J Biotechnol. 2016 Dec 10;239:1-8. doi: 10.1016/j.jbiotec.2016.09.031. Epub 2016 Oct 1.

PMID:
27702574
16.

The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis.

Yada M, Miyazaki M, Motomura K, Masumoto A, Nakamuta M, Kohjima M, Sugimoto R, Aratake Y, Higashi N, Morizono S, Takao S, Yamashita N, Satoh T, Yamashita S, Kuniyoshi M, Kotoh K.

J Gastrointest Oncol. 2016 Aug;7(4):615-23. doi: 10.21037/jgo.2016.03.10.

17.

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

Kudo M, Hatano E, Ohkawa S, Fujii H, Masumoto A, Furuse J, Wada Y, Ishii H, Obi S, Kaneko S, Kawazoe S, Yokosuka O, Ikeda M, Ukai K, Morita S, Tsuji A, Kudo T, Shimada M, Osaki Y, Tateishi R, Sugiyama G, Abada PB, Yang L, Okusaka T, Zhu AX.

J Gastroenterol. 2017 Apr;52(4):494-503. doi: 10.1007/s00535-016-1247-4. Epub 2016 Aug 22.

PMID:
27549242
18.

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.

Okanoue T, Shima T, Hasebe C, Karino Y, Imazeki F, Kumada T, Minami M, Imai Y, Yoshihara H, Mita E, Morikawa T, Nishiguchi S, Kawakami Y, Nomura H, Sakisaka S, Kurosaki M, Yatsuhashi H, Oketani M, Kohno H, Masumoto A, Ikeda K, Kumada H.

Hepatol Res. 2016 Sep;46(10):992-1001. doi: 10.1111/hepr.12638. Epub 2016 Jan 18.

PMID:
26670363
19.

Transient generation of hydrogen peroxide is responsible for carcinostatic effects of hydrogen combined with platinum nanocolloid, together with increases intracellular ROS, DNA cleavages, and proportion of G2/M-phase.

Saitoh Y, Ikeshima M, Kawasaki N, Masumoto A, Miwa N.

Free Radic Res. 2016;50(4):385-95. doi: 10.3109/10715762.2015.1131823. Epub 2016 Feb 12.

PMID:
26652652
20.

Effects of Cyclophosphamide Pulse Therapy on the Clinical and Histopathological Findings, Particularly Crescent Formation, in a Patient with Adult-onset Steroid-refractory Henoch-Schönlein Purpura Nephritis.

Tanaka Y, Nakashima Y, Mima T, Ohya M, Yamamoto S, Kobayashi S, Masumoto A, Masumoto K, Yano T, Moribata M, Yoshimoto W, Yamanaka S, Koreeda D, Hanba Y, Tatsuta K, Sakaguchi T, Negi S, Shigematsu T.

Intern Med. 2015;54(17):2207-11. doi: 10.2169/internalmedicine.54.4330. Epub 2015 Sep 1.

21.

Mineral Composition of Phosphate-Induced Calcification in a Rat Aortic Tissue Culture Model.

Sonou T, Ohya M, Yashiro M, Masumoto A, Nakashima Y, Ito T, Mima T, Negi S, Kimura-Suda H, Shigematsu T.

J Atheroscler Thromb. 2015;22(11):1197-206. doi: 10.5551/jat.28647. Epub 2015 Jun 27.

22.

Safety and efficacy evaluation of lanthanum carbonate for hyperphosphatemia in end-stage renal disease patients.

Shigematsu T, Ohya M, Negi S, Masumoto AR, Nakashima YM, Iwatani Y, Moribata MK, Yamanaka S, Tatsuta K, Mima T.

Contrib Nephrol. 2015;185:42-55. doi: 10.1159/000380969. Epub 2015 May 19.

PMID:
26023014
23.

[Hange-Shashin-to for preventing diarrhea during afatinib therapy].

Yamaguchi O, Kawashima A, Shiono A, Maeno Y, Ishikawa R, Masumoto A, Utsugi H, Daito H, Okano T, Murayama Y, Kobayashi K.

Gan To Kagaku Ryoho. 2015 May;42(5):581-3. Japanese.

PMID:
25981651
24.

Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.

Yada M, Masumoto A, Motomura K, Tajiri H, Morita Y, Suzuki H, Senju T, Koyanagi T.

World J Gastroenterol. 2014 Sep 21;20(35):12581-7. doi: 10.3748/wjg.v20.i35.12581.

25.

Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.

Mori T, Kanbara T, Harumiya M, Iwase Y, Masumoto A, Komiya S, Nakamura A, Shibasaki M, Kanemasa T, Sakaguchi G, Suzuki T.

J Pharmacol Sci. 2014;126(1):47-55. Epub 2014 Aug 20.

26.

[Rapid specific IgE assay (ImmunoCAP® RAPID) and skin prick test in the diagnosis of allergic disease].

Komiyama K, Masumoto A, Nishihara F, Kobayashi T, Soma T, Hagiwara K, Kanazawa M, Nagata M.

Arerugi. 2013 Dec;62(12):1631-41. Japanese.

PMID:
24608652
27.

[A case of lung paragonimiasis superinfection with hookworm presenting difficulty in discrimination].

Minezaki S, Hirama T, Shiono A, Masumoto A, Mio T, Utsugi H, Uchida Y, Kaga A, Hagiwara K, Kanazawa M.

Kansenshogaku Zasshi. 2013 Nov;87(6):756-60. Japanese.

PMID:
24483024
28.

[Case report; a case of lung and skin nocardiosis in a non-immunocompromised patient].

Masumoto A, Hirama T, Kawana H, Kawashima A, Shiono A, Mio T, Nagata M, Hagiwara K, Kanazawa M.

Nihon Naika Gakkai Zasshi. 2013 Oct 10;102(10):2679-81. Japanese. No abstract available.

PMID:
24400549
29.

Nighttime snacking reduces whole body fat oxidation and increases LDL cholesterol in healthy young women.

Hibi M, Masumoto A, Naito Y, Kiuchi K, Yoshimoto Y, Matsumoto M, Katashima M, Oka J, Ikemoto S.

Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15;304(2):R94-R101. doi: 10.1152/ajpregu.00115.2012. Epub 2012 Nov 21.

30.

[Kidney and bone update : the 5-year history and future of CKD-MBD. Progress of phosphate binders].

Hanba Y, Masumoto A, Moribata M, Shigemathu T.

Clin Calcium. 2012 Jul;22(7):1059-71. doi: CliCa120710591071. Review. Japanese.

PMID:
22750939
31.

Effects of intermittent high glucose on BeWo choriocarcinoma cells in culture.

Masumoto A, Takamoto N, Masuyama H, Akahori Y, Inoue S, Hiramatsu Y.

J Obstet Gynaecol Res. 2011 Oct;37(10):1365-75. doi: 10.1111/j.1447-0756.2011.01539.x. Epub 2011 May 22.

PMID:
21599799
32.

Expression of antiangiogenic prolactin fragments in the placentas of women with pregnancy induced hypertension.

Masumoto A, Masuyama H, Takamoto N, Akahori Y, Hiramatsu Y.

Acta Med Okayama. 2010 Aug;64(4):249-55.

33.

Circulating levels of ciliary neurotrophic factor in normal pregnancy and preeclampsia.

Akahori Y, Takamoto N, Masumoto A, Inoue S, Nakatsukasa H, Masuyama H, Hiramatsu Y.

Acta Med Okayama. 2010 Apr;64(2):129-36.

34.

Immediate virological response predicts the success of short-term peg-interferon monotherapy for chronic hepatitis C.

Yada M, Masumoto A, Yamashita N, Motomura K, Koyanagi T, Sakamoto S.

World J Gastroenterol. 2010 Mar 28;16(12):1506-11.

35.

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y.

BJOG. 2010 Feb;117(3):314-20. doi: 10.1111/j.1471-0528.2009.02453.x. Epub 2009 Dec 10.

36.

Successful management of anti-Jra alloimmunization in pregnancy: a case report.

Masumoto A, Masuyama H, Sumida Y, Segawa T, Hiramatsu Y.

Gynecol Obstet Invest. 2010;69(2):81-3. doi: 10.1159/000259724. Epub 2009 Nov 19.

PMID:
19923849
37.

Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension.

Inoue S, Takamoto N, Akahori Y, Masumoto A, Nakatsukasa H, Msuyama H, Hiramatsu Y.

J Obstet Gynaecol Res. 2009 Apr;35(2):293-300.

PMID:
19708176
38.

Relation between neonatal jaundice and oncostatin M, hepatocyte growth factor and soluble gp130 levels in umbilical cord.

Nakatsukasa H, Masuyama H, Akahori Y, Inoue S, Masumoto A, Hiramatsu Y.

Acta Obstet Gynecol Scand. 2008;87(12):1322-8. doi: 10.1080/00016340802468332.

PMID:
18972232
39.

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group.

Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Masumoto A, Maruyama T, Nakamuta M, Enjoji M, Azuma K, Shimono J, Sakai H, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1094-104. doi: 10.1111/j.1440-1746.2008.05319.x. Epub 2008 Feb 3.

PMID:
18248381
40.

UV protection and singlet oxygen quenching activity of aloesaponarin I.

Nagaoka S, Fujii A, Hino M, Takemoto M, Yasuda M, Mishima M, Ohara K, Masumoto A, Uno H, Nagashima U.

J Phys Chem B. 2007 Nov 15;111(45):13116-23. Epub 2007 Oct 19. Erratum in: J Phys Chem B. 2012 Feb 23;116(7):2338.

PMID:
17949031
41.
42.

Hepatocellular carcinoma arising from autoimmune hepatitis: report of a case.

Okino H, Satoh T, Watanabe J, Masumoto A, Takeda S.

Surg Today. 2007;37(8):716-8. Epub 2007 Jul 26.

PMID:
17643223
43.

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

Nakamuta M, Kotoh K, Enjoji M, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Tanabe Y, Hayashi J.

Comp Hepatol. 2007 May 1;6:3.

44.

Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.

Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H.

J Cardiovasc Pharmacol. 2007 Mar;49(3):117-21.

PMID:
17414222
45.

Continuous large-scale production of the cytokine CXCL8 from a novel porcine cell line.

Shirai J, Ogihara K, Masumoto A, Morioka K, Naya Y, Tsuchiya Y, Yokomizo Y.

Eur Cytokine Netw. 2007 Mar;18(1):14-22. Epub 2007 Mar 30.

46.

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H.

Hepatology. 2007 Jan;45(1):118-27.

PMID:
17187436
47.

Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.

Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, Hiramatrsu Y.

Am J Obstet Gynecol. 2006 Dec;195(6):1687-92. Epub 2006 Jun 12.

PMID:
16769024
48.

Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.

Suwaki N, Masuyama H, Masumoto A, Takamoto N, Hiramatsu Y.

Placenta. 2007 Apr;28(4):315-23. Epub 2006 Jun 6.

PMID:
16753211
49.

Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.

Furusyo N, Katoh M, Tanabe Y, Kajiwara E, Maruyama T, Shimono J, Sakai H, Nakamuta M, Nomura H, Masumoto A, Shimoda S, Takahashi K, Azuma K, Hayashi J; Kyushu University Liver Disease Study Group.

World J Gastroenterol. 2006 Feb 7;12(5):784-90.

50.

Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.

Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J.

World J Gastroenterol. 2006 Jan 28;12(4):561-7.

Supplemental Content

Loading ...
Support Center